Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

112.05 -0.73 (-0.64%)
Streaming Delayed Price Updated: 10:39 AM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,630
Open 112.16
Bid (Size) 111.96 (2)
Ask (Size) 112.28 (2)
Prev. Close 112.78
Today's Range 110.67 - 112.28
52wk Range 79.88 - 131.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
This big pharma company's juicy dividend is looking even more attractive. 
Via The Motley Fool
Topics Earnings
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and federal health policy. 
Via Benzinga

Performance

YTD
-2.8%
-2.8%
1 Month
+0.9%
+0.9%
3 Month
+21.7%
+21.7%
6 Month
+0.1%
+0.1%
1 Year
+35.3%
+35.3%

More News

Read More
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
Via Benzinga
Breaking Down BioNTech: 12 Analysts Share Their Views
Via Benzinga
These Analysts Revise Their Forecasts On BioNTech After Q2 Results
Via Benzinga
BioNTech Gets Price Target Bumps From BofA, Clear Street After Strong Q2, Oncology Pipeline Push
Via Stocktwits
Earnings Scheduled For August 4, 2025
Via Benzinga
A Look Ahead: BioNTech's Earnings Forecast
Via Benzinga
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
Via Benzinga
BioNTech SE (NASDAQ:BNTX) Q2 2025 Earnings: Revenue Surges 68.5%, Losses Narrower Than Expected
Via Chartmill
Topics Earnings
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Moderna's Key Patent Win Overshadowed By Gloomy Outlook
Via Benzinga
Topics Intellectual Property
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
Via Benzinga
Where Will Pfizer (PFE) Be in 5 Years?
Via The Motley Fool
Topics Intellectual Property
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
Via Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
From BioNTech SE
Via GlobeNewswire
BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
From BioNTech SE
Via GlobeNewswire
BioNTech Announces Ryan Richardson to Step Down from the Management Board
From BioNTech SE
Via GlobeNewswire
Breaking Down BioNTech: 12 Analysts Share Their Views
Via Benzinga
Why Is AbbVie Stock Trading Higher On Thursday?
Via Benzinga
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
Via Benzinga
Topics Intellectual Property
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
Via Benzinga
Ex-Pfizer Exec Pulled Into House Probe Over Alleged COVID Vaccine Delay Through 2020 Election
Via Stocktwits
Topics Government Law Enforcement

Frequently Asked Questions

Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 112.05
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 08/14/25 10:39 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.